Composite Variability Index Versus Bispectral Index (BIS)

NCT01053611 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Sedation During

Interventions

DRUG: propofol + remifentanil 0 ng/ml
DRUG: propofol + remifentanil 2 ng/ml
DRUG: propofol + remifentanil 4 ng/ml
DRUG: propofol + remifentanil 6 ng/ml
DRUG: propofol + remifentanil 0 ng/ml
DRUG: propofol + remifentanil 2 ng/ml
DRUG: propofol + remifentanil 6 ng/ml
DRUG: propofol + remifentanil 6 ng/ml
DRUG: propofol + remifentanil 0 ng/ml
DRUG: propofol + remifentanil 2 ng/ml
DRUG: propofol + remifentanil 4 ng/ml
DRUG: propofol + remifentanil 6 ng/ml

Sponsor

University Medical Center Groningen